Abstract Results
Women with polycystic ovary syndrome (PCOS) frequently suffer from metabolic disturbances, in particular from prediabetes and diabetes.
Conflicting results currently exists on the relationship between vitamin D and glucose metabolism. Hence, the aim of our study was to investigate the association of 25 (OH) D levels and glucose tolerance in PCOS women.
Our results suggest that low 25 (OH) D levels are associated with diabetes and glucose intolerance in PCOS women. Large intervention trials are warranted to evaluate the effect of Vitamin D supplementation on glucose metabolic disturbances in PCOS women.
Serum 25(OH) D concentrations was 18,8 ± 7,5 ng/ml. The prevalence of 25(OH) D insufficient (<30 ng/ml) and deficiency (<10 ng/ml) was 88% and 16% respectively. Only one woman with PCOS was Vitamin D sufficiency (> 30 ng/ml).Three (12%), four (16%) and 16 (64%) women were patients with diabetes, glucose intolerance and normoglycemia respectively. PCOS women with glucose disturbance had lower 25(OH)D levels than PCOS women with normoglycemia (13,7± 7,5 ng/ml vs 21,03± 6,6 ng/ml p<0,05). In binary logistic regression analyses, 25(OH)D (OR 0,84, p<0,05) was independent predictors of glucose metabolic alteration in PCOS women. We found significantly negative correlations of 25 (OH)D level with basal glucose (r:-0,44, p<0,05).
Cross-sectional study including 23 PCOS patients (mean age 27 years). 25(OH) D levels were measured by chemiluminiscence (Cobas e 601 by ROCHE). Standard 75 g oral glucose tolerance test were performed. Results were analyzed by SPSS 18.0..
